These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease). Sahu S J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747 [No Abstract] [Full Text] [Related]
3. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Liggins GC; Howie RN Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295 [No Abstract] [Full Text] [Related]
4. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids]. Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249 [No Abstract] [Full Text] [Related]
5. [The role of steroid therapy in the prevention of respiratory distress syndrome in the newborn]. Szabó I; Csaba I; Novák P; Drozgyik I Orv Hetil; 1977 Mar; 118(10):566-8. PubMed ID: 840473 [No Abstract] [Full Text] [Related]
6. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature]. Gandibleux-Bergiers MF J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311 [TBL] [Abstract][Full Text] [Related]
7. Prevention of hyaline membrane disease. Br Med J; 1973 Apr; 2(5858):65-6. PubMed ID: 4700320 [No Abstract] [Full Text] [Related]
8. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study]. Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029 [TBL] [Abstract][Full Text] [Related]
9. Respiratory distress syndrome: the preventive use of glucocorticoids. Haller CC; King CR J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085 [No Abstract] [Full Text] [Related]
10. [Effect of glucocorticoids in preventing the idiopathic respiratory distress syndrome in low-weight infants]. Ognianov K; Dimitrov M; Daskalova E Akush Ginekol (Sofiia); 1978; 17(3):157-60. PubMed ID: 354423 [No Abstract] [Full Text] [Related]
11. New frontiers in prenatal prevention of respiratory distress syndrome. Cosmi EV J Perinat Med; 1991; 19 Suppl 1():170-5. PubMed ID: 1779354 [No Abstract] [Full Text] [Related]
13. Plasminogen in the prevention of hyaline membrane disease. Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209 [No Abstract] [Full Text] [Related]
14. Prenatal glucocorticoids for prevention of the respiratory distress syndrome. Med Lett Drugs Ther; 1976 Jul; 18(14):59. PubMed ID: 934020 [No Abstract] [Full Text] [Related]
15. [Prenatal prevention of the respiratory syndrome. I. Current status of knowledge]. Meriggi E; Parenti MR Minerva Ginecol; 1980 Mar; 32(3):175-86. PubMed ID: 6103524 [No Abstract] [Full Text] [Related]
16. [Use of glucocorticoids in prevention of the respiratory distress syndrome]. de Oliveira RL; dos Santos MC; Candido DF; el'Debs I Rev Centro Cienc Biomed Univ Fed Uberlandia; 1987 Dec; 3(1):41-7. PubMed ID: 3078405 [TBL] [Abstract][Full Text] [Related]
17. Respiratory distress in the newborn. Can Med Assoc J; 1968 Jun; 98(22):1070. PubMed ID: 5652453 [No Abstract] [Full Text] [Related]